S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom

Cipher Pharmaceuticals (CPH) Competitors

C$8.82
-0.09 (-1.01%)
(As of 04/17/2024 ET)

CPH vs. CRDL, HLS, OGI, ACB, GUD, HTL, QIPT, VHI, DR, and SVA

Should you be buying Cipher Pharmaceuticals stock or one of its competitors? The main competitors of Cipher Pharmaceuticals include Cardiol Therapeutics (CRDL), HLS Therapeutics (HLS), Organigram (OGI), Aurora Cannabis (ACB), Knight Therapeutics (GUD), Hamilton Thorne (HTL), Quipt Home Medical (QIPT), Vitalhub (VHI), Medical Facilities (DR), and Sernova (SVA). These companies are all part of the "medical" sector.

Cipher Pharmaceuticals vs.

Cipher Pharmaceuticals (TSE:CPH) and Cardiol Therapeutics (TSE:CRDL) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, community ranking, analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment and earnings.

Cipher Pharmaceuticals received 170 more outperform votes than Cardiol Therapeutics when rated by MarketBeat users. However, 66.67% of users gave Cardiol Therapeutics an outperform vote while only 62.68% of users gave Cipher Pharmaceuticals an outperform vote.

CompanyUnderperformOutperform
Cipher PharmaceuticalsOutperform Votes
178
62.68%
Underperform Votes
106
37.32%
Cardiol TherapeuticsOutperform Votes
8
66.67%
Underperform Votes
4
33.33%

Cipher Pharmaceuticals presently has a consensus price target of C$8.00, suggesting a potential downside of 9.30%. Given Cipher Pharmaceuticals' higher probable upside, equities research analysts clearly believe Cipher Pharmaceuticals is more favorable than Cardiol Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cipher Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Cardiol Therapeutics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Cipher Pharmaceuticals has a net margin of 96.32% compared to Cardiol Therapeutics' net margin of 0.00%. Cipher Pharmaceuticals' return on equity of 28.19% beat Cardiol Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Cipher Pharmaceuticals96.32% 28.19% 8.06%
Cardiol Therapeutics N/A -59.88%-34.61%

1.0% of Cipher Pharmaceuticals shares are held by institutional investors. Comparatively, 13.4% of Cardiol Therapeutics shares are held by institutional investors. 44.7% of Cipher Pharmaceuticals shares are held by company insiders. Comparatively, 4.0% of Cardiol Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Cipher Pharmaceuticals has higher revenue and earnings than Cardiol Therapeutics. Cardiol Therapeutics is trading at a lower price-to-earnings ratio than Cipher Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cipher PharmaceuticalsC$21.16M10.00C$20.38MC$1.098.09
Cardiol TherapeuticsN/AN/A-C$28.01M-C$0.43-5.63

Cipher Pharmaceuticals has a beta of 0.97, suggesting that its share price is 3% less volatile than the S&P 500. Comparatively, Cardiol Therapeutics has a beta of 0.75, suggesting that its share price is 25% less volatile than the S&P 500.

In the previous week, Cardiol Therapeutics had 2 more articles in the media than Cipher Pharmaceuticals. MarketBeat recorded 2 mentions for Cardiol Therapeutics and 0 mentions for Cipher Pharmaceuticals. Cipher Pharmaceuticals' average media sentiment score of 0.00 equaled Cardiol Therapeutics'average media sentiment score.

Company Overall Sentiment
Cipher Pharmaceuticals Neutral
Cardiol Therapeutics Neutral

Summary

Cipher Pharmaceuticals beats Cardiol Therapeutics on 12 of the 15 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CPH vs. The Competition

MetricCipher PharmaceuticalsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$211.59MC$1.17BC$4.73BC$5.00B
Dividend YieldN/A3.02%5.40%6.65%
P/E Ratio8.091,200.61225.1122.95
Price / Sales10.0010,101.752,430.151,482.01
Price / Cash3.5310.7247.4775.97
Price / Book2.633.364.603.10
Net IncomeC$20.38MC$105.73MC$101.21MC$293.43M
7 Day Performance5.63%-1.84%-4.63%-2.60%
1 Month Performance8.89%4.91%-4.32%14.59%
1 Year Performance157.89%20.73%10.56%16.99%

Cipher Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CRDL
Cardiol Therapeutics
0 of 5 stars
C$2.58
+1.6%
N/A+254.4%C$167.98MN/A-6.00N/ANews Coverage
HLS
HLS Therapeutics
0.0672 of 5 stars
C$4.99
-1.0%
C$4.58
-8.3%
-20.2%C$159.28MC$63.07M-4.3091Gap Up
OGI
Organigram
2.3968 of 5 stars
C$2.86
-4.3%
C$3.62
+26.6%
+250.7%C$269.13MC$149.21M-1.14984Upcoming Earnings
ACB
Aurora Cannabis
0.2024 of 5 stars
C$8.61
-8.9%
C$2.26
-73.7%
+839.1%C$469.59MC$275.88M-0.111,130Gap Down
High Trading Volume
GUD
Knight Therapeutics
1.3225 of 5 stars
C$5.57
+0.5%
C$6.58
+18.2%
+20.0%C$563.52MC$328.20M-34.81725News Coverage
Positive News
HTL
Hamilton Thorne
0 of 5 stars
C$1.32
flat
N/AN/AC$200.46MC$65.21M44.00N/A
QIPT
Quipt Home Medical
0 of 5 stars
C$5.45
-0.9%
C$11.74
+115.4%
N/AC$229.45MC$235.72M-45.42N/A
VHI
Vitalhub
1.0336 of 5 stars
C$6.20
+0.6%
C$6.17
-0.5%
+143.3%C$271.00MC$52.51M62.00353Analyst Report
Analyst Revision
News Coverage
DR
Medical Facilities
0.1959 of 5 stars
C$11.04
+2.2%
C$12.00
+8.7%
+40.0%C$272.91MC$445.58M11.151,833
SVA
Sernova
0.6621 of 5 stars
C$0.42
-12.6%
C$1.50
+261.4%
-44.6%C$125.92MN/A-3.191,959High Trading Volume

Related Companies and Tools

This page (TSE:CPH) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners